Sudhir Rawal

7PUBLICATIONS
37CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular medicineTissue engineering
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 14, 2026
Integrative multi-omics analysis identifies histone methyltransferase SUV420H2 as a prognostic biomarker in clear cell renal cell carcinoma.

|Jan 09, 2024
2/1 dose schedule of sunitinib is superior than the 4/2 regimen for the first-line therapy of clear cell metastatic renal cell carcinoma - An Indian experience.

Jiten Jaipuria, Ankita Jain, Shashikant Gupta

|Oct 30, 2023
Enzalutamide-Induced Acute Maculopapular Rash in Treatment of Metastatic Prostate Cancer: First Case Report from a Tertiary Cancer Care Center of North India.

Arnab Chakraborty, Ashish Khanna, Vivek Vasudeo

|Oct 30, 2023
Cutaneous Radiation-Associated Angiosarcoma After Treatment of Carcinoma Penis: First Report from Tertiary Cancer Centre of North India.

Sarbartha Kumar Pratihar, Ashish Khanna, Arnab Chakraborty

|Apr 27, 2022
Pitcher pot neourethral modification of ileal orthotopic neobladder achieves satisfactory long-term functional and quality of life outcomes with low clean intermittent self-catheterization rate.

Jiten Jaipuria, Ahmad Mamoon Karimi, Amitabh Singh

|Aug 27, 2021
Outcomes in robot-assisted partial nephrectomy for imperative vs elective indications.

Jo-Lynn S Tan, Niranjan Sathianathen, Marcus Cumberbatch

Pageof 2

Frequent Collaborators

4 joint publications

Amitabh Singh

3 joint publications

Ashish Khanna

2 joint publications

Sarbartha Kumar Pratihar

2 joint publications

Arnab Chakraborty